Related Experiment Video
Updated: Apr 23, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Retinal Microvascular Dysfunction Reflects Vascular and Alzheimer's-Related Pathology in Dementia With Lewy Bodies
Qiuling Tong1, William Robert Kwapong2, Xiaoqian Luan3
1Neurology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Ouhai, China.
Background:
Dementia with Lewy bodies (DLB) frequently coexists with cerebrovascular injury and Alzheimer's-related pathology, yet accessible in vivo markers of these processes remain limited. The retinal microvasculature shares structural and physiological characteristics with cerebral small vessels and may provide a non-invasive window into neurovascular and neurodegenerative pathology.
Methods:
In this cross-sectional study, 32 individuals with DLB and 31 age-matched cognitively unimpaired controls (CU) underwent swept-source optical coherence tomography angiography (OCTA), brain MRI, and plasma biomarker assessment. Retinal vessel densities of the superficial vascular complex (SVC), deep vascular complex (DVC), and choriocapillaris (CC) were quantified. Plasma amyloid-β, phosphorylated tau-217 (p-tau217), and glial fibrillary acidic protein were measured. Cerebral small vessel disease (SVD) burden and white matter hyperintensity (WMH) volumes were derived from MRI. Associations with cognition and mediation by WMH burden were evaluated using generalized estimating equations and bootstrapped mediation analyses.
Results:
Compared with CU, individuals with DLB exhibited significantly reduced SVC, DVC, and CC vessel densities (all p < 0.001). Lower retinal vessel densities were associated with higher plasma amyloid burden and elevated p-tau217, as well as greater SVD burden and periventricular WMH volume. APOE ε4 carriers demonstrated more pronounced retinal microvascular impairment, higher WMH burden, and elevated p-tau217 levels than non-carriers. Reduced SVC density was associated with worse global cognition, and this relationship was partially mediated by periventricular WMH volume.
Conclusions:
Retinal microvascular impairment measured by OCTA is closely linked to Alzheimer's-related plasma biomarkers, SVD, and cognitive decline in DLB. These findings support retinal OCTA as a scalable, non-invasive biomarker reflecting convergent neurodegenerative and vascular pathology in DLB.
Insights
Retinal microvascular impairment detected by OCTA is linked to Alzheimer's biomarkers and cognitive decline in Dementia with Lewy bodies (DLB). This non-invasive OCTA imaging offers a new window into DLB's complex neurodegenerative and vascular changes.
Area of Science:
- Neuroscience
- Ophthalmology
- Radiology
Background:
- Dementia with Lewy bodies (DLB) often involves cerebrovascular and Alzheimer's pathology.
- Accessible in vivo biomarkers for these coexisting conditions in DLB are limited.
- Retinal microvasculature may serve as a non-invasive indicator of cerebral small vessel changes.
Purpose of the Study:
- To investigate the relationship between retinal microvascular density and neurodegenerative/vascular markers in DLB.
- To explore retinal OCTA as a potential biomarker for DLB pathology.
- To assess associations between retinal findings, plasma biomarkers, and cognitive function.
Main Methods:
- Cross-sectional study involving 32 DLB patients and 31 controls.
- Utilized swept-source optical coherence tomography angiography (OCTA) for retinal imaging.
- Collected plasma biomarkers (amyloid-β, p-tau217) and brain MRI (SVD, WMH) data.
Main Results:
- DLB patients showed significantly reduced retinal vessel densities in SVC, DVC, and CC compared to controls.
- Lower retinal vessel densities correlated with higher amyloid burden, p-tau217, SVD, and white matter hyperintensities (WMH).
- Reduced SVC density was associated with poorer global cognition, partly mediated by WMH.
Conclusions:
- Retinal microvascular impairment via OCTA is associated with Alzheimer's biomarkers, SVD, and cognitive decline in DLB.
- OCTA provides a scalable, non-invasive biomarker for DLB.
- Findings highlight OCTA's potential to reflect combined neurodegenerative and vascular pathology in DLB.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Related Concept Videos
Diabetic Retinopathy
Dementia l: Introduction